​

Doximity (DOCS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DOCS Stock Forecast

Doximity (DOCS) stock forecast, based on 18 Wall Street analysts, predicts a 12-month average price target of $55.00, with a high of $65.00 and a low of $43.00. This represents a -3.42% decline from the last price of $56.95.

$20 $29 $38 $47 $56 $65 High: $65 Avg: $55 Low: $43 Last Closed Price: $56.95

DOCS Stock Rating

Doximity stock's rating consensus is Buy, based on 18 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (55.56%), 8 Hold (44.44%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 18 0 8 10 Strong Sell Sell Hold Buy Strong Buy

DOCS Price Target Upside V Benchmarks

TypeNameUpside
StockDoximity-3.42%
SectorHealthcare Stocks 24.81%
IndustryHealthcare Information Services Stocks 29.27%

Price Target Trends

1M3M12M
# Anlaysts3314
Avg Price Target$55.67$55.67$52.86
Last Closing Price$56.95$56.95$56.95
Upside/Downside-2.25%-2.25%-7.18%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 253511--19
May, 253511--19
Apr, 253511--19
Mar, 253512--20
Feb, 252413--19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 20, 2025David RomanGoldman Sachs$50.00$53.00-5.66%-12.20%
May 16, 2025Jailendra SinghTruist Financial$52.00$52.56-1.07%-8.69%
May 16, 2025Brian PetersonRaymond James$65.00$52.5623.67%14.14%
Jan 13, 2025Stan BerenshteynWells Fargo$43.00$55.48-22.49%-24.50%
Jan 08, 2025Scott SchoenhausKeyBanc$65.00$55.4817.16%14.14%
Nov 14, 2024Jailendra SinghTruist Financial$49.00$52.60-6.84%-13.96%
Nov 13, 2024Richard CloseCanaccord Genuity$60.00$35.6068.54%5.36%
Nov 08, 2024Scott BergNeedham$65.00$57.6012.85%14.14%
Nov 08, 2024Stan BerenshteynWells Fargo$41.00$42.09-2.59%-28.01%
Nov 08, 2024Scott SchoenhausKeyBanc$70.00$43.4261.22%22.91%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 20, 2025Goldman SachsNeutralNeutralhold
May 16, 2025Raymond JamesOutperformOutperformhold
Apr 16, 2025KeyBancOverweightOverweighthold
Feb 07, 2025NeedhamBuyBuyhold
Jan 08, 2025KeyBancOverweightOverweighthold
Nov 14, 2024Morgan StanleyUnderweightEqual-Weightupgrade
Nov 13, 2024Canaccord GenuityHolddowngrade
Nov 08, 2024Bank of America SecuritiesNeutralNeutralhold
Nov 08, 2024KeyBancOverweightupgrade
Oct 15, 2024BarclaysEqual-WeightOverweightupgrade

Financial Forecast

EPS Forecast

Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$0.81$0.58$0.78$1.19----
Avg Forecast$0.77$0.70$0.90$1.15$1.26$1.42$1.65$1.76
High Forecast$0.78$0.73$0.91$1.21$1.38$1.82$1.72$1.84
Low Forecast$0.76$0.68$0.88$1.12$1.15$1.17$1.59$1.71
Surprise %5.19%-17.14%-13.33%3.48%----

Revenue Forecast

$300M $420M $540M $660M $780M $900M Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$343.55M$419.05M$475.42M$570.40M----
Avg Forecast$339.84M$418.16M$473.82M$539.96M$596.32M$657.01M$728.72M$856.10M
High Forecast$344.57M$433.02M$474.06M$543.62M$626.49M$658.14M$754.62M$886.53M
Low Forecast$335.52M$408.11M$473.58M$537.50M$572.44M$655.89M$711.21M$835.53M
Surprise %1.09%0.21%0.34%5.64%----

Net Income Forecast

$100M $160M $220M $280M $340M $400M Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$154.78M$112.82M$147.58M$223.19M----
Avg Forecast$158.06M$143.70M$137.63M$240.13M$260.04M$306.97M$338.64M$362.09M
High Forecast$160.92M$150.34M$165.16M$249.48M$282.92M$373.71M$354.29M$378.82M
Low Forecast$155.45M$139.22M$110.11M$230.77M$237.16M$240.24M$328.06M$350.78M
Surprise %-2.07%-21.49%7.23%-7.05%----

DOCS Forecast FAQ

Is Doximity stock a buy?

Doximity stock has a consensus rating of Buy, based on 18 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 8 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Doximity is a favorable investment for most analysts.

What is Doximity's price target?

Doximity's price target, set by 18 Wall Street analysts, averages $55 over the next 12 months. The price target range spans from $43 at the low end to $65 at the high end, suggesting a potential -3.42% change from the previous closing price of $56.95.

How does Doximity stock forecast compare to its benchmarks?

Doximity's stock forecast shows a -3.42% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the healthcare information services stocks industry (29.27%).

What is the breakdown of analyst ratings for Doximity over the past three months?

  • June 2025: 15.79% Strong Buy, 26.32% Buy, 57.89% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 15.79% Strong Buy, 26.32% Buy, 57.89% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 15.79% Strong Buy, 26.32% Buy, 57.89% Hold, 0% Sell, 0% Strong Sell.

What is Doximity’s EPS forecast?

Doximity's average annual EPS forecast for its fiscal year ending in March 2026 is $1.26, marking a 5.88% increase from the reported $1.19 in 2025. Estimates for the following years are $1.42 in 2027, $1.65 in 2028, and $1.76 in 2029.

What is Doximity’s revenue forecast?

Doximity's average annual revenue forecast for its fiscal year ending in March 2026 is $596.32M, reflecting a 4.54% increase from the reported $570.4M in 2025. The forecast for 2027 is $657.01M, followed by $728.72M for 2028, and $856.1M for 2029.

What is Doximity’s net income forecast?

Doximity's net income forecast for the fiscal year ending in March 2026 stands at $260.04M, representing an 16.51% increase from the reported $223.18M in 2025. Projections indicate $306.97M in 2027, $338.64M in 2028, and $362.09M in 2029.